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Summary 
Macrophage activation is deficient in the fetus and neonate when the serum concentrations of 
docosahexaenoic acid (DHA)  are  150  p.M,  or 10-50-fold higher than in the adult. We now 
show that DHA inhibits production of nitric oxide (NO) by macrophages stimulated in vitro 
by IFN~/plus LPS, or by IFNy plus TNF~x. The half-maximal inhibitory activity of DHA was 
,'~25  p~M. There were strict biochemical requirements of the fatty acid for inhibition.  Poly- 
enoic fatty acids with 22 carbons were more inhibitory than those with 20 carbons. Among 22- 
carbon fatty acids, those with a greater number of double bonds and a double bond in the n-3 
position were more inhibitory. DHA was the most inhibitory of the polyenoic acids we tested. 
Inducible nitric oxide synthase (iNOS) is the enzyme responsible for the production of NO 
by macrophages. NO production is initiated after new iNOS enzyme is synthesized following 
transcription of the iNOS gene. In macrophages stimulated by IFN~/plus LPS, DHA inhibited 
accumulation ofiNOS mRNA, as measured by Northern blotting, and iNOS transcription, as 
measured by nuclear run-on assays. We transfected RAW 264.7 macrophages with a construct 
containing the iNOS promoter fused to the chloramphenicol acetyl transferase gene. DHA in- 
hibited activation of this promoter by IFN~/plus LPS. By inhibiting iNOS transcription in the 
fetus and neonate, DHA may contribute to their increased susceptibility to infection. 
D 
eficits in macrophage functions in the fetus, the neo- 
nate, and the parts of the placenta peffused by the fe- 
tal circulation may contribute to the increased susceptibility 
of  the fetoplacental unit and newborn to infection (1, 2). De- 
spite deficient functions in vivo, murine  neonatal macro- 
phages can be activated to kill P815  mastocytoma cells (3) 
and express Ia in vitro (4). This suggests  the presence of an 
inhibitor of macrophage activation in the perinatal internal 
environment. 
We  have  chosen  to  investigate  docosahexaenoic  acid 
(DHA)  as one inhibitor of fetal and neonatal macrophage 
activation. The serum concentrations of DHA in the day- 
old rat are 150 p.M and decline during the first weeks after 
birth to levels of"-~5 p.M (5).  Similar large differences be- 
tween fetal and adult concentrations of  DHA have also been 
documented in Rhesus monkeys (6),  and can be calculated 
in human,  rat, and pig from the amounts of DHA known 
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to  be  bound  to  its  physiologic  carrier  protein  AFP  (7). 
DHA is a major fatty acid constituent of brain and retina, 
and  the  high  fetal serum  levels  may be  required  for the 
rapid intrauterine growth and development of  these tissues (8). 
Nitric  oxide  (NO)  produced by activated macrophages 
may be one  effector molecule in  the host  defense against 
intracellular pathogens (9,  10). We now show that DHA, at 
concentrations present in the fetal and neonatal serum, in- 
hibited  NO  production  by  macrophages  stimulated  by 
IFNy and LPS in vitro.  NO  production by macrophages 
results when  the  gene for inducible  nitric  oxide  synthase 
(iNOS)  is activated,  and new enzyme is produced.  Tran- 
scription of the iNOS gene was inhibited by DHA. 
Materials and Methods 
Reagents.  R+10 media was RPMI-1640 with 10 mM Hepes, 
2 mM t-glutamine, 50 U/ml penicillin,  50 mg/ml streptomycin, 
and 10 % FCS. R§  itself contained 3 ~M DHA and 3.3 p,M 
AA  (7). Murine  recombinant  IFN~/ and  TNFct  were  from 
GIBCO BILL (Grand  Island,  NY)  and  Genzyme (Cambridge, 
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5,8,11,14-eicosapentaenoic acid  [or arachidonic acid  (AA)], and 
cis-5,8,11,14,17-eicosapentaenoic  acid were from Cayman Chemi- 
cal Co.  (Ann Arbor, MI). Docosanoic acid,  trans-13-docosenoic 
acid  (brassidic acid),  cis-13-docosenoic  acid  (or erucic acid), cis- 
13,16-docosatrienoic  acid,  cis-13,16,19-docosatrienoic  acid,  and 
cis 7,10,13,16-docosatetraenoic acid were from Sigma Chemical 
Co.  (St. Louis,  MO).  All reagents,  except the  LPS  itsels  con- 
tained less than .012 ng/ml endotoxin by the Limulus Amebocyte 
Lysate (LAL) assay. 
Macrophages.  Peritoneal exudate was harvested from C3H/NIH 
mice 4 d after 1.5 cc 3% thioglycollate  ip. Mice were housed ac- 
cording to NIH and institutional guidelines.  5  ￿  104 peritoneal 
exudate cells were placed  in each well of 96-well flat microtiter 
plates (Catalog no. 3596, CoStar,  Cambridge, MA), incubated in 
R+10,  5%  CO  2,  37~  for  24--48  h,  and washed  twice  with 
RPMI-1640.  Over  95%  of the  remaining adherent cells were 
macrophages. 
Measurement of NO.  NO is rapidly converted to nitrite which 
was  assayed using the  Greiss  reagent  (1%  sulfanilamide,  0.1% 
N-(1-naphthyl) ethylenediamine  dihydrochloride in 2.5% H3PO4) 
(10, 11). 50 rul of the supematant from each well was incubated 
for 10 rain with 50 ml of Griess reagent.  Optical densities were 
then obtained on a TiterTech Multiskan at 540  nm (using 690 
nm as  a reference).  NO  2 in the samples was  calculated  from a 
standard curve using NaNO  z. All values shown are the mean -+ 
SEM of triplicate wells. 
Delipidated Human  Serum Albumin  (lISA).  Albumin was  de- 
lipidated using acid charcoal  (7,  12). R+ 10 containing 8 uM of 
delipidated  albumin had 0.10 p~M palmitic acid, 0.20 p~M stearic 
acid,  0.08  p~M oleic  acid,  0.02 p~M linoleic acid,  and 0.00  p,M 
(undetectable amounts) ofpalmitooleic, arachidonic, and docosa- 
hexaenoic acids (7). 
Fatty Acid-HSA  Complexes.  All the  fatty  acids were  used as 
complexes of fatty acid bound to delipidated HSA. The fatty acids 
were stored under N2, -20~  at a concentration of 20 mg/cc in 
ethanol. On the day of the experiment, the fatty acids were ex- 
amined by thin-layer chromatography on KG Silica Gel plates 
(Whatman  International Ltd,  Maidstone,  England)  using ethyl 
ether/petroleum ether/acetic  acid  50/50/1  (vol/vol/vol). Oxi- 
dized samples were discarded.  HSA (100 mg/cc in RPMI) was 
added  directly  to  the  fatty  acid  (20 mg/cc)  such that  the  fatty 
acid/HSA molar ratio  was  6:1.  The  samples  were  thoroughly 
flushed with nitrogen, sealed, covered with aluminum foil, vor- 
texed for 10 rain, and incubated at 37~  for ~2 h. The desired fi- 
nal dilutions were  then prepared  in R+10.  100 uM fatty  acid 
contained 0.165%  ethanol. We found that this concentration of 
ethanol did not affect NO production. The proper formation of 
these DHA/HSA complexes  was critical. The presence of DHA 
as micelles, as opposed to DHA/HSA complexes,  would result in 
toxicity to the macrophages. 
Northern Blotting.  Total RNA was isolated from 1 ￿  107 macro- 
phages using the single-step guanidinium  thiocyanate method (13). 
After electrophoresis  on a 1% agarose gel, the mRNA was trans- 
ferred to GeneScreen Plus membranes (NEN Research Products, 
Boston, MA), hybridized for 16-18 h at 42~  with [32p]-dCTP 
nick-labeled DNA  probes  for  iNOS  or  cyclophilin (Promega 
Prime-a-Gene Kit;  Madison,  WI).  Membranes  were  washed 
twice  in both  0.1%SDS/1%  SSC  (15  rain) and  1%  SDS/0.1% 
SSC  (1  h) before autoradiography.  The cDNA probes were the 
664-bp AccI  fragment of iNOS  cDNA  (14), and the  743-bp 
EcoRI-HindlII fragment ofcyclophilin cDNA (15). 
Nuclear Run-onAssay.  Nuclei  from  107  macrophages  were 
isolated as previously described  (16). pCMV plasmids containing 
the  cDNA  inserts  for  iNOS,  described  above,  or  a  1.1-kb 
BamHI-HindlII fragment  of glyceraldehye-3-phosphate dehy- 
drogenase (GAPDH) (17) were denatured and placed onto Gene- 
Screen  Plus  membranes using a  slot-blot  apparatus  (Bio-Rad 
Labs., Hercules,  CA). Nascent 32p-labeled mRNA was hybrid- 
ized with the immobilized DNA for 48 h, washed,  and then de- 
tected by autoradiography.  The densities  of the resultant bands 
were  analyzed  using a  GS300  Transmittance/Reflectance scan- 
ning densitometer (Hoeffer Scientific, San Francisco, CA). 
CATAssays.  The pliNOS-CAT construct (a generous gift 
from Drs.  Xie and Nathan [18]) contained 1,749  bp of the 5'- 
flanking region of the murine iNOS gene fused to the chloram- 
phenicol acetyl transferase gene. RAW 264.7  macrophages  were 
transiently transfected,  and analyzed for CAT activity  according 
to previously published techniques (18). 
Results  and Discussion 
We chose to use DHA bound to carrier protein because 
nonesterified DHA in fetal and newborn serum is bound to 
hydrophobic areas of the AFP carrier protein (19).  Delipi- 
dated HSA rather than AFP was chosen as the carrier pro- 
tein for two reasons: (a) HSA is similar to AFP in structure, 
and has  hydrophobic binding sites  for  nonesterified fatty 
acids (20, 21). (b) Unlike AFP, HSA is readily available, and 
has not been reported to regulate macrophage activation (22). 
We found that DHA inhibited NO production by mac- 
rophages stimulated by IFN~/plus LPS  (Fig.  1).  The half- 
maximum inhibitory concentration of DHA was approxi- 
mately 25  p~M, and  is  comparable  to  the  concentrations 
found in fetal and neonatal sera (5,  7). Fig. 2 indicates that 
increasing amounts of IFN~ or LPS did not reverse the in- 
Figure 1.  Inhibition of NO production by various doses of DHA or 
AA. Macrophages were stimulated  for 24 h by IFN'y (100 U/rnl) plus LPS 
(100 ng/ml) in the presence or absence of DHA or AA. The conditioned 
media was assayed for NO (as nitrite). The DHA (solid bars) or AA (cross- 
hatched bars) were administered as fatty acids bound to HSA. The top 
x-axis is the HSA concentration;  the bottom x-axis, the fatty acid concen- 
tration. Macrophages stimulated  by neither 1FN~ nor LPS produced 1.0 
-+ 0.2 uM NO. The mean  and standard error of triplicate determinations 
are shown. 
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Figure 2.  Effects  of different doses of IFN'y and LPS on DHA inhibi- 
tion. Macrophages were  cultured  as in Fig. 1 in the presence of media 
only (open bars), HSA  (cross-hatched bars), or 100 uM DHA (solid bars). 
Macrophages stimulated  by 100 ng/cc LPS plus the amounts  of IFN"/ 
shown on the x-axis  (a), or  100 U/cc  IFN~/ plus the amounts  of LPS 
shown on the x-axis (b). 
hibition. Furthermore,  NO  production was  similar in the 
presence  of media  only versus  delipidated HSA.  This  ex- 
cludes  the  possibility that  HSA  was  interfering  with  the 
LPS-macrophage interaction. 
DHA  was,  by far,  the  most  inhibitory of the  nine 20- 
and 22-carbon fatty acids tested  (Fig.  3),  and was the only 
one  of these  present  at  high  concentrations  in  fetal  and 
neonatal sera  (23).  AA  and EPA  are  of particular interest 
(Fig. 3  a). Both are 20-carbon polyenoic acids. AA is an n-6 
fatty acid which is a major polyenoic fatty acid in the phos- 
pholipids  of humans fed  the  usual American diet,  and ro- 
dents fed standard laboratory chow. EPA and DHA are both 
n-3 fatty acids found in large amounts in phospholipids  of 
animals fed  fish  oil-enriched  diets  (8).  Among  22-carbon 
fatty acids (Fig. 3  b), inhibition generally increased with the 
Figure 3.  Inhibitory effects of DHA versus other fatty acids. Macro- 
phages were cultured as in Fig. 1. The fine dotted line (IFN7 +  LPS + 
HSA 17 I~M) is the NO released by macrophages stimulated with these 
agents, but no fatty acid. In the absence of IFN3~ or LPS, no detectable 
NO was produced.  (a) DHA is all cis-4,7,10,13,16,19  docosahexaenoic 
acid (6 double bonds, 22 carbons, n-3); EPA is all c/s-5,8,11,14,17-eicosa- 
pentaenoic acid (5 double bonds, 20 carbons, n-3); AA is arachidonic acid 
or 5,8,11,14-eicosatetraenoic  acid (4 double bonds, 20 carbons, n-6) (b) 
DAA is docosanoic acid (22 carbons, zero double bonds); DEA is c/s-13- 
docosenoic acid (22 carbons, 1 double bond, n-9); DDA is all cis-13,16 
docosadienoic acid  (22 carbons, 2  double  bonds,  n-9); DTiA is all cis- 
13,16,19-docosatrienoic acid (22 carbons, 3 double bonds, n-3); DTeA is 
all cis 7,10,13,16 docosatetraenoic acid, 22 carbons, 4 double bonds, n-6); 
and DHA is all cis 4,7,10,13,16,19 docosabexaenoic acid (6 double bonds, 
22 carbons, n-3). 
number of double bonds.  However,  docosatetraenoic  acid 
(DTeA),  with  four double bonds,  was  less inhibitory than 
docosatrienoic acid (DTiA), with three double bonds.  This 
indicates the  importance  of the  n-3  double bond because 
DTiA is an n-3 fatty acid while DTeA is n-6. Remarkably, 
a similar pattern of inhibition occurred when we examined 
IFN~/-induced ]a expression by macrophages (24). 
Three  sets  of data  indicated that  DHA  inhibited iNOS 
gene transcription. First, DHA inhibited the increased iNOS 
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macrophages stimulated by IFN~/plus LPS. Macrophages  were stimulated 
with media or with IFN~/(100 U/ml) plus LPS (100 ng/ml) in the pres- 
ence of  50 uM DHA, AA, or the HSA carrier protein. At the end ofa 20-h 
culture period, the abundance of iNOS and cyclophilin mRNA was de- 
termined by Northern analysis. See text for densitometry. 
mRNA  abundance  caused by IFN~/plus LPS  (Fig. 4).  By 
densitometry, the ratio ofiNOS: cyclophilin mRAXlA abun- 
dance was zero in macrophages cultured in media alone, and 
increased  to 0.97  after macrophages were stimulated  with 
IFN~/ plus  LPS.  The  ratio  was  1.07  in  stimulated  macro- 
phages exposed to AA. DHA decreased this  ratio  to 0.55. 
Second, nuclear run-on assays showed that DHA inhibited 
iNOS  mRNA  transcription  stimulated by IFN~/plus  LPS 
(Fig. 5). By densitometry, the ratio of  nascent iNOS mRNA 
to GAPDH mRNA  was 0.64  in macrophages cultured in 
media,  increased  to 7.76  after stimulation  with  IFN~/plus 
LPS, and decreased to 2.44 after exposure to DHA, IFN~/ 
and LPS. This inhibition ofmRNA  transcription was simi- 
lar  to  the  inhibition  of NO  production  by  DHA:  IFN~/ 
plus  LPS  stimulated  macrophages produced  49  I~M  NO; 
DHA decreased  this  to  22  I~M,  or 44%  of the  stimulated 
amount.  Third,  we  transfected  RAW  264.7  macrophages 
with  a  construct  containing the  iNOS  promoter fused  to 
the CAT gene (18). As shown in Fig. 6, IFN~/plus LPS ac- 
tivated the promoter, and DHA prevented activation.  The 
percent  acetylated  chloramphenicol,  determined  by phos- 
phoimagery, was 0.82% for A  (media),  3.84% for B  (IFN~/ 
+  LPS), and 1.56% for C  (IFN~/  +  LPS +  DHA). 
Inhibition  by DHA was  not  a  nonspecific  toxic  effect. 
DHA did not inhibit the ability ofmacrophages to ingest and 
catabolize bacteria (7),  nor the conversion of 3-(4,5-dimeth- 
ylthiazol-l-yl)-2,5-diphenyltetrazolium  (MTT)  to  its  for- 
mazan by the mitochondrial electron transport system (24). 
The effects of DHA on several other macrophage activa- 
tion pathways has been examined. We found that DHA in- 
hibited NO production ifTNFet was substituted for the LPS 
Figure 5.  DHA inhibits transcription of iNOS n~NA. Macrophages 
were cultured either in media, IFN~/ (100 U/ml) plus LPS (100 ng/ml), 
or IFN~/plus LPS and DHA 50 p~M. (Top) A photomicrograph  of  the nu- 
clear run-on  autoradiograph. (Middle) Densitometry data. (Bottom) NO 
production. 
portion  of IFN~/  plus  LPS  stimulation.  Inhibition  ranged 
from approximately  60% at low  doses  of IFN~/  +  TNFot 
stimulation,  to 30% at higher doses of IFNot +  TNFot. We 
previously  reported  that  DHA  inhibited  macrophage  Ia- 
expression after stimulation by IFN~/or IL-4 (24), and lysis 
of the  TNFot-resistant  (25)  P815  mastocytoma cells  after 
stimulation by IFN~/plus LPS (7).  Others have shown that 
production  of TNFot  after  stimulation  by LPS in  vitro  is 
not inhibited by DHA (26). 
Fig-are  6.  DHA inhibits acti- 
vation of the pliNOS promoter 
in  a  CAT  assay. RAW  264.7 
were transfected with  pliNOS, 
and  then  aliquoted onto  three 
dishes.  Dish A  received media 
only. Dish B received IFN~/(100 
U/ml)  plus LPS  (100 ng/ml). 
Dish C received IFN~/plus LPS 
plus DHA (50 txM). 
1244  Docosahexaenoic  Acid Inhibits iNOS Gene Transcription Our data may help explain the increased susceptibility of 
the fetus,  neonate,  and placenta  to intracellular  pathogens 
such as Listeria monocytogenes (27). The concentrations of 
DHA which inhibit NO production are present in neonatal 
and fetal serum  (5,  7) and those areas of the placenta per- 
fused by the fetal circulation. 
AFP has a special role in maintaining the high fetal con- 
centrations  of DHA.  This  70,000-mol  wt glycoprotein is 
present  at  concentrations  of 5-10  mg/ml  in  fetal  serum 
during the  first  trimester  in humans  and  throughout fetal 
life  in  rodents.  Maximum  concentrations  in  the  maternal 
serum,  on the  other hand,  do not exceed 500  ng/ml  (for 
review see reference 20).  DHA has a much higher affinity 
for AFP in the fetal circulation than for albumin in the ma- 
ternal circulation, and therefore DHA partitions to the fetal 
circulation (19). The DHA in the fetal and neonatal serum 
is bound to AFP. DHA bound to AFP may be the mole- 
cule actually responsible  for the  inhibition  of macrophage 
activation previously attributed to AFP (22, 28). 
DHA is a major fatty acid component offish oil diets (29). 
Inhibition  of NO  production  by  macrophages  by  DHA 
may also contribute to the beneficial effects of  such diets on 
some autoimmune diseases  (for example see references 31- 
33), and preventing transplant rejection (34). 
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